المؤلفون: Frenel, J.-S.^{Aff1, IDs41416023022484_cor1}, Lusque, A., Delaloge, S., Ferrero, J.-M., Bachelot, T., Desmoulins, I., Levy, C., Eymard, J.-C., Gonçalves, A., Patsouris, A., Reynier, M. A. Mouret, Thery, M. J.-C., Petit, T., Cabel, L., Uwer, L., Debled, M., Chevrot, M., Mailliez, A., Jacot, W., de La Motte Rouge, T.

المصدر: British Journal of Cancer. 128(11):2072-2080

المؤلفون: Penault-Llorca, F., Dalenc, F., Chabaud, S., Cottu, P., Allouache, D., Cameron, D., Grenier, J., Venat Bouvet, L., Jegannathen, A., Campone, M., Debled, M., Hardy-Bessard, A.-C., Giacchetti, S., Barthelemy, P., Kaluzinski, L., Mailliez, A., Mouret-Reynier, M.-A., Legouffe, E., Cayre, A., Martinez, M., Delbaldo, C., Mollon-Grange, D., Macaskill, E.J., Sephton, M., Stefani, L., Belgadi, B., Winter, M., Orfeuvre, H., Lacroix-Triki, M., Bonnefoi, H., Bliss, J., Canon, J.-L., Lemonnier, J., Andre, F., Bachelot, T.

المصدر: In ESMO Open May 2024 9(5)

المؤلفون: Blaye, C., Darbo, É., Debled, M., Brouste, V., Vélasco, V., Pinard, C., Larmonier, N., Pellegrin, I., Tarricone, A., Arnedos, M., Commeny, J., Bonnefoi, H., Larmonier, C., MacGrogan, G.

المصدر: In ESMO Open August 2022 7(4)

المؤلفون: Bringuier, M.^{Aff1, IDs10549021064672_cor1}, Carton, M., Levy, C., Patsouris, A., Pasquier, D., Debled, M., Rigal, O., Jacot, W., Gonçalves, A., Desmoulins, I., De La Motte Rouge, T., Bachelot, T., Ferrero, J.-M., Eymard, J.-C., Ung, M., Mouret-Reynier, M.-A., Petit, T., Chevrot, M., Uwer, L., Courtinard, C., Frenel, J.-S., Vianzone, A., Baldini, C.

المصدر: Breast Cancer Research and Treatment. 191(3):577-587

المؤلفون: Grinda, T., Antoine, A., Jacot, W., Blaye, C., Cottu, P.-H., Diéras, V., Dalenc, F., Gonçalves, A., Debled, M., Patsouris, A., Mouret-Reynier, M.-A., Mailliez, A., Clatot, F., Levy, C., Ferrero, J.-M., Desmoulins, I., Uwer, L., Petit, T., Jouannaud, C., Lacroix-Triki, M., Deluche, E., Robain, M., Courtinard, C., Bachelot, T., Brain, E., Pérol, D., Delaloge, S.

المصدر: In ESMO Open June 2021 6(3)

المؤلفون: Carausu, M., Carton, M., Darlix, A., Pasquier, D., Leheurteur, M., Debled, M., Mouret-Reynier, M.A., Goncalves, A., Dalenc, F., Verret, B., Campone, M., Augereau, P., Ferrero, J.M., Levy, C., Fumet, J.-D., Lefeuvre-Plesse, C., Petit, T., Uwer, L., Jouannaud, C., Larrouquere, L., Chevrot, M., Courtinard, C., Cabel, L.

المصدر: In ESMO Open June 2021 6(3)

المؤلفون: Puszkiel A; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier - Toulouse III, 2 Avenue Hubert Curien, Toulouse 31100, France., Dalenc F; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Tafzi N; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France., Marquet P; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France., Debled M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Jacot W; Institut du Cancer de Montpellier, ICM, Université de Montpellier, IRCM, Inserm U1194, Montpellier, France., Venat-Bouvet L; Department of Medical Oncology, CHU Limoges, Limoges, France., Ferrer C; Department of Medical Oncology, CHU Nîmes-Carémeau, Nîmes, France., Levasseur N; Department of Medical Oncology, CH Cahors, Cahors, France., Paulon R; Department of Medical Oncology, Centre Hospitalier Intercommunal Castres-Mazamet, Castres, France., Dauba J; Department of Medical Oncology, CH Mont de Marsan, Mont-de-Marsan, France., Evrard A; Institut du Cancer de Montpellier, ICM, Université de Montpellier, IRCM, Inserm U1194, Montpellier, France; Laboratoire de Biochimie et Biologie Moléculaire, CHU Nîmes-Carémeau, Nîmes, France., Mauriès V; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Filleron T; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Chatelut E; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier - Toulouse III, 2 Avenue Hubert Curien, Toulouse 31100, France; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Thomas F; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier - Toulouse III, 2 Avenue Hubert Curien, Toulouse 31100, France; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., White-Koning M; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier - Toulouse III, 2 Avenue Hubert Curien, Toulouse 31100, France. Electronic address: melanie.white-koning@univ-tlse3.fr.

المصدر: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Aug 01; Vol. 199, pp. 106809. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE

مواضيع طبية MeSH: Letrozole*/pharmacokinetics , Letrozole*/administration & dosage , Letrozole*/therapeutic use , Letrozole*/blood , Breast Neoplasms*/drug therapy , Breast Neoplasms*/metabolism , Medication Adherence* , Aromatase Inhibitors*/pharmacokinetics , Aromatase Inhibitors*/administration & dosage , Aromatase Inhibitors*/therapeutic use , Aromatase Inhibitors*/blood, Humans ; Female ; Middle Aged ; Aged ; Adult ; Chemotherapy, Adjuvant/methods ; Models, Biological ; Prospective Studies ; Receptors, Estrogen/metabolism ; Antineoplastic Agents/pharmacokinetics ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/blood ; Antineoplastic Agents/administration & dosage ; Aged, 80 and over

المؤلفون: Giacchetti S; AP-HP, Hôpital Saint Louis, Senologie, Paris and Chronotherapy, Cancers, and Transplantation Unit, Faculty of Medicine, Paris-Saclay University, France; Chronotherapy, Cancers and Transplatation Unit, Faculty of Medicine, Paris-Saclay, Villejuif, France. Electronic address: sylvie.giacchetti@aphp.fr., Laas E; Surgery Department, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France., Bachelot T; Medical Oncology, Centre Leon Berard, Lyon, France., Lemonnier J; R&D Unicancer, Paris, France., André F; Gustave Roussy, Villejuif, France., Cameron D; ICR-CTSU, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Bliss J; Medical Oncology, Western General Hospital, Edinburgh, United Kingdom., Chabaud S; Department of Clinical Research and Innovation, Centre Leon Berard, Lyon, France., Hardy-Bessard AC; Medical Oncology, CARIO, Plerin, France., Lacroix-Triki M; Gustave Roussy, Villejuif, France., Canon JL; Medical Oncology, Grand Hopital de Charleroi, Charleroi, Belgium., Debled M; Medical Oncology, Institut Bergonie, Bordeaux, France., Campone M; Medical Oncology, Institut Cancerologie de l'Ouest, Saint Herblain, France., Cottu P; Medical Oncology, Institut Curie, Universite Paris Cite, Paris, France., Dalenc F; Medical Oncology, Oncopole Claudius Regaud, IUCT, Toulouse, France., Ballesta A; U900, Institut Curie, Saint Cloud, France., Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Clermont Ferrand, France., Asselain B; Arcagy-Gineco, Paris, France., Dumas E; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France; Department of Mathematics, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; (t)'Chronotherapy, Cancers, and Transplantation' Unit, Faculty of Medicine, Paris-Saclay University, Villejuif, France., Reyal F; Surgery Department, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France., Gougis P; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France., Lévi F; Chronotherapy, Cancers and Transplatation Unit, Faculty of Medicine, Paris-Saclay, Villejuif, France., Hamy AS; Medical Oncology, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France.

المصدر: EBioMedicine [EBioMedicine] 2024 Jun; Vol. 104, pp. 105141. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/mortality , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism, Adult ; Aged ; Female ; Humans ; Middle Aged ; Antineoplastic Agents, Hormonal/therapeutic use ; Antineoplastic Agents, Hormonal/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant/methods ; Circadian Rhythm ; Disease-Free Survival ; Neoplasm Staging ; Tamoxifen/administration & dosage ; Tamoxifen/therapeutic use ; Treatment Outcome ; Prospective Studies

المؤلفون: Gougis, P., Carton, M., Tchokothe, C., Campone, M., Dalenc, F., Mailliez, A., Levy, C., Jacot, W., Debled, M., Leheurteur, M., Bachelot, T., Hennequin, A., Perrin, C., Gonçalves, A., Uwer, L., Eymard, J.C., Petit, T., Mouret-Reynier, M.A., Chamorey, E., Simon, G., Saghatchian, M., Cailliot, C., Le Tourneau, C.

المصدر: In The Breast February 2020 49:17-24

المؤلفون: Salaün H; Department of Medical Oncology, Institut Curie, Paris, France., Djerroudi L; Department of Pathology-Genetics-Immunology, Institut Curie, Paris, France., Haik L; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Schnitzler A; Department of Pathology-Genetics-Immunology, Institut Curie, Paris, France., Bataillon G; Department of Pathology-Genetics-Immunology, Institut Curie, Paris, France., Deniziaut G; Department of Pathology-Genetics-Immunology, Institut Curie, Paris, France., Bièche I; Department of Pathology-Genetics-Immunology, Institut Curie, Paris, France.; Paris-Cité University, Paris, France., Vincent-Salomon A; Department of Pathology-Genetics-Immunology, Institut Curie, Paris, France.; PSL Research University, Paris, France., Debled M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Cottu P; Department of Medical Oncology, Institut Curie, Paris, France.; Paris-Cité University, Paris, France.

المصدر: The journal of pathology. Clinical research [J Pathol Clin Res] 2024 May; Vol. 10 (3), pp. e12372.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Wiley Blackwell Country of Publication: England NLM ID: 101658534 Publication Model: Print Cited Medium: Internet ISSN: 2056-4538 (Electronic) Linking ISSN: 20564538 NLM ISO Abbreviation: J Pathol Clin Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/metabolism, Female ; Humans ; Middle Aged ; Class I Phosphatidylinositol 3-Kinases/genetics ; Everolimus/therapeutic use ; Prognosis ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; TOR Serine-Threonine Kinases/metabolism ; Aged